Vicore Pharma Holding AB (publ) engages in the research and development of pharmaceutical products for the treatments for rare lung diseases. The company is developing VP01, a small molecule compound for oral administration that is in phase II clinical trial for the treatment of interstitial lung diseases, idiopathic pulmonary fibrosis (IPF), systemic sclerosis, and COVID-19; and VP02, a formulation and delivery route for an existing immunomodulatory compound, which is preclinical trials to treat patients with IPF. It has a cooperation and development agreement with Emeriti Bio AB; license agreement with Nanologica AB (publ); and a collaboration agreement with Alex Therapeutics AB for the development and clinical validation of a digital therapeutic (DTx) built on the Alex DTx platform. The company was formerly known as Mintage Scientific AB. Vicore Pharma Holding AB (publ) was founded in 2000 and is headquartered in Gothenburg, Sweden. The 2025 version of the report offers detailed insights into the company's strategies, developments, outlook and drivers. In addition to SWOT Analysis and Financial Overview, the report analyzes key projects, business description, products, services, brands, operating locations, subsidiaries and affiliates of Vicore Pharma Holding.
Vicore Pharma Holding business operations across the value chain are included. Further, all major operating and planned locations, related contacts, details of subsidiaries and partnerships of Vicore Pharma Holding are also analyzed.
Detailed
SWOT Analysis of the company including key strengths and weaknesses of Vicore Pharma Holding , on which it can build its business along with potential opportunities and threats in the near to medium term future are detailed.
Key employees of the company including the management team and board of directors are listed with their designations. Further, statistics on key parameters such as employee count, organization structure etc is provided.
Financial analysis of Vicore Pharma Holding including key ratios, income statement, cash flow statement and balance sheet are provided for the company. In addition, Key historical events, summary analysis of Vicore Pharma Holding and all latest updates of the company are provided.
The 2025 version of Vicore Pharma Holding report is presented after intensive primary and secondary research processes and it presents the insights in a complete impartial and reader friendly format.
TABLE OF CONTENTS
1.1 List of Tables
1.2 List of Figures
2 Introduction to the Company
2.1 Vicore Pharma Holding- Key Facts
2.2 Vicore Pharma Holding- Geographic Locations
2.3 Vicore Pharma Holding- Subsidiaries and Affiliates
2.4 Vicore Pharma Holding- Business Divisions
2.5 Vicore Pharma Holding- Key Employees
2.5.1 Management Team
2.5.2 Board of Directors
3. Vicore Pharma Holding Strategic Analysis Review
3.1 Vicore Pharma Holding- Key Strategies
3.2 Vicore Pharma Holding- Company Outlook Statement
3.3 Vicore Pharma Holding- SWOT Analysis
3.3.1 Vicore Pharma Holding- Key Strengths
3.3.2 Vicore Pharma Holding- Key Weaknesses
3.3.3 Vicore Pharma Holding- Potential Opportunities
3.3.4 Vicore Pharma Holding- Potential Threats
3.4 Vicore Pharma Holding- Key Competitors
4. Business Description of the Company
4.1 Vicore Pharma Holding- Business Overview
4.2 Vicore Pharma Holding- Operations by Segment
5 Products and Services Details
5.1 Vicore Pharma Holding- Key Products
5.2 Vicore Pharma Holding- Key Service Areas
5.3 Vicore Pharma Holding- Key Brands
6 Company Developments
6.1 Vicore Pharma Holding- Company History
6.2 Vicore Pharma Holding- Latest Developments
7 Financial Analysis
7.1 Vicore Pharma Holding- Income Statements
7.2 Vicore Pharma Holding- Balance Sheet
7.3 Vicore Pharma Holding- Cash Flow Statements
8 Competitors and Industry Analysis
8.1 Vicore Pharma Holding- Direct Competitors
8.2 Vicore Pharma Holding- Competitor Financial Ratios comparison
8.3 Vicore Pharma Holding- Competitor Stock Charts Comparison
8.4 Vicore Pharma Holding- Industry Analysis
9 Appendix
9.1 About SWOTreports
9.2 Sources and Methodology
9.3 Contact Information
P.S.Financial Analysis will be provided only for companies reporting financial data.
Get Free Sample
At SWOT Reports, we understand the importance of informed decision-making in today's dynamic business landscape. To help you experience the depth and quality of our market research reports, we offer complimentary samples tailored to your specific needs.
Start Now! Please fill the form below for your free sample.
Why Request a Free Sample?
Evaluate Our Expertise: Our reports are crafted by industry experts and seasoned analysts. Requesting a sample allows you to assess the depth of research and the caliber of insights we provide.
Tailored to Your Needs: Let us know your industry, market segment, or specific topic of interest. Our free samples are customized to ensure relevance to your business objectives.
Witness Actionable Insights: See firsthand how our reports go beyond data, offering actionable insights and strategic recommendations that can drive your business forward.
Embark on your journey towards strategic decision-making by requesting a free sample from SWOT Reports. Experience the caliber of insights that can transform the way you approach your business challenges.
FAQ's
Gain valuable insights into the company for academic or business research purposes with this comprehensive profile. Key elements, such as SWOT analysis and corporate strategy, are included to support your research needs effectively.
Customer and Supplier Identification: Analyze the company’s business structure, operations, major products, services, and strategies to identify potential customers and suppliers.
Leverage a detailed SWOT analysis to understand and evaluate your competitors' business structures, strategies, and core performance metrics. This analysis offers an up-to-date and objective perspective on the company’s strengths, weaknesses, opportunities, and threats.
Didn’t find what you’re looking for? TALK TO OUR ANALYST TEAM
Need something within your budget? NO WORRIES! WE GOT YOU COVERED!
Reach Out to Us
Industries
Resources
Company
Sign up for Offers & Promotions
- Connect with us
- +91 630 95 25755
- sales@swotreports.com
-
Chat on WhatsApp
